Agios Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	76.25	88.21	139.26	203.13
Short-Term Investments	-	817.46	688.72	643.86	816.89
Cash & Short-Term Investments	952.86	893.71	776.93	783.12	1,020
Cash Growth	6.62%	15.03%	-0.79%	-23.23%	78.04%
Accounts Receivable	-	4.11	2.81	2.21	-
Other Receivables	-	-	1.1	0.3	7.28
Receivables	-	4.11	3.91	2.51	7.28
Inventory	-	27.62	19.08	8.49	-
Prepaid Expenses	-	40.17	33.92	38.66	36.94
Total Current Assets	-	965.6	833.84	832.77	1,064
Property, Plant & Equipment	-	54.55	69.79	88.12	104.23
Long-Term Investments	-	638.32	29.44	313.87	266.38
Other Long-Term Assets	-	4.72	4.06	3.96	2.9
Total Assets	-	1,663	937.12	1,239	1,438
Accounts Payable	-	16.64	9.78	18.62	16.7
Accrued Expenses	-	46.86	43.17	30.35	31.97
Current Portion of Leases	-	16.78	15.01	13.66	11.16
Current Income Taxes Payable	-	0.87	-	-	-
Total Current Liabilities	-	81.16	67.96	62.63	59.83
Long-Term Leases	-	40.21	56.99	72	85.94
Other Long-Term Liabilities	-	0.88	1.16	3.28	-
Total Liabilities	-	122.24	126.1	137.9	145.76
Common Stock	-	0.07	0.07	0.07	0.07
Additional Paid-In Capital	-	2,494	2,437	2,386	2,334
Retained Earnings	-	-148.92	-822.65	-470.56	-238.76
Treasury Stock	-	-802.49	-802.49	-802.49	-802.49
Comprehensive Income & Other	-	-1.52	-0.44	-12.54	-1.2
Shareholders' Equity	1,284	1,541	811.02	1,101	1,292
Total Liabilities & Equity	-	1,663	937.12	1,239	1,438
Total Debt	44.52	56.99	72	85.66	97.09
Net Cash (Debt)	1,213	1,475	734.37	1,011	1,189
Net Cash Growth	-17.79%	100.86%	-27.39%	-14.96%	110.37%
Net Cash Per Share	20.92	25.48	13.20	18.46	19.67
Filing Date Shares Outstanding	58.31	57.3	56.19	55.29	54.64
Total Common Shares Outstanding	58.28	57.16	55.95	55.04	54.33
Working Capital	-	884.44	765.88	770.14	1,004
Book Value Per Share	22.04	26.96	14.50	20.00	23.78
Tangible Book Value	1,284	1,541	811.02	1,101	1,292
Tangible Book Value Per Share	22.04	26.96	14.50	20.00	23.78
Machinery	-	29.76	29.73	35.12	33.8
Construction In Progress	-	0.9	0.61	0.66	7.37
Leasehold Improvements	-	37.52	37.28	37.28	32.73

Source: S&P Global Market Intelligence. Standard template. Financial Sources.